The Effect of Previous Pneumococcal Immunization on the Immune Response of Adult Patients With Severe Chronic Kidney Disease to Prevnar 13
Phase of Trial: Phase IV
Latest Information Update: 18 Jul 2017
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- 10 Jul 2017 Planned End Date changed from 1 May 2017 to 1 May 2019.
- 10 Jul 2017 Planned primary completion date changed from 1 May 2017 to 1 May 2018.
- 06 Jul 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.